BMS' last work with Stand Up To Cancer was a fall lung cancer PSA campaign with actor Common. Now the pharma is funding a lung cancer research team. (Photo by Paras Griffin/Getty Images)
June 1, 2022 01:16 PM EDTUpdated 04:46 PM
Pharma
Marketing

BMS, Mi­rati fund new Stand Up To Can­cer re­search teams, adding to list of phar­ma part­ner­ships

Beth Snyder Bulik

Senior Editor

Stand Up To Can­cer is well-known for its celebri­ty con­nec­tions and gala fundrais­ing events, but in phar­ma and biotech, it’s al­so known as a re­search …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times